Tactile Reports Q1 2025 Earnings with Slight Revenue Growth
Tactile (TCMD) reported a slight increase in total revenue for the first quarter of 2025, growing by 0.3% year-over-year to $61.3 million. However, its lymphedema business line saw a decline in revenue by 3%. The earnings call included forward-looking statements and non-GAAP financial measures.
Topics: financial performance lymphedema business revenue growth